Invesco Ltd. Acorda Therapeutics Inc Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.61 - $2.5 $125,367 - $194,670	-77,868 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.3 - $4.71 $11,598 - $23,752	-5,043 Reduced 6.08%	77,868 $186,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.79 $9,757 - $13,910	2,904 Added 3.63%	82,911 $381,000
Q2 2021 Aug 17, 2021	SELL	$3.61 - $5.23 $2,436 - $3,530	-675 Reduced 0.84%	80,007 $382,000
Q1 2021 May 17, 2021	BUY	$3.8 - $8.04 $306,591 - $648,683	80,682 New	80,682 $393,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.